{
    "info": {
        "nct_id": "NCT06075810",
        "official_title": "A Phase 1 Open-Label, First-in-Human Trial of Oral MBQ-167 as Single Agent in Participants With Advanced Breast Cancer",
        "inclusion_criteria": "* The investigator will evaluate these and other criteria to determine whether a participant can be included in this study.\n* Histologically and/or cytologically confirmed advanced breast cancer which has progressed after treatment with approved therapies or for which there are no standard therapies available.\n* Participants with known brain metastases may be eligible if specific conditions are met.\n* Life expectancy ≥6 months, in the opinion of the investigator, after starting MBQ-167.\n* Are able to swallow capsules twice daily with a meal.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
        "exclusion_criteria": "* The investigator will evaluate these and other criteria to determine whether a participant should be excluded from this study.\n* Inability to take oral medication, or malabsorption syndrome or any other uncontrolled gastrointestinal condition (e.g., nausea, diarrhea, or vomiting) that might impair the bioavailability of MBQ-167.\n* Females who are pregnant or breastfeeding.\n* Participants who have received any anticancer treatment within 4 weeks or any investigational agent within 28 days prior to the first dose of trial drug or who have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment.\n* Participants who have received any anticancer treatment within 4 weeks or any investigational agent within 28 days prior to the first dose of trial drug or who have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment.\n* Active malignancies other than advanced breast cancer will be excluded from the study.",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key eligibility criteria",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "N/A"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Are able to swallow capsules twice daily with a meal.",
            "criterions": [
                {
                    "exact_snippets": "Are able to swallow capsules",
                    "criterion": "ability to swallow capsules",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "twice daily with a meal",
                    "criterion": "capsule administration schedule",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": "=",
                                "value": 2,
                                "unit": "times per day"
                            }
                        },
                        {
                            "requirement_type": "with meal",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically and/or cytologically confirmed advanced breast cancer which has progressed after treatment with approved therapies or for which there are no standard therapies available.",
            "criterions": [
                {
                    "exact_snippets": "Histologically and/or cytologically confirmed advanced breast cancer",
                    "criterion": "advanced breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation",
                            "expected_value": [
                                "histologically confirmed",
                                "cytologically confirmed"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "which has progressed after treatment with approved therapies",
                    "criterion": "advanced breast cancer progression",
                    "requirements": [
                        {
                            "requirement_type": "progression after approved therapies",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for which there are no standard therapies available",
                    "criterion": "standard therapies availability",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 21 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 21 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 21,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with known brain metastases may be eligible if specific conditions are met.",
            "criterions": [
                {
                    "exact_snippets": "Participants with known brain metastases may be eligible",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy ≥6 months, in the opinion of the investigator, after starting MBQ-167.",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy ≥6 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "in the opinion of the investigator",
                    "criterion": "investigator opinion of life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "investigator assessment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "after starting MBQ-167",
                    "criterion": "timing of life expectancy assessment",
                    "requirements": [
                        {
                            "requirement_type": "reference point",
                            "expected_value": "after starting MBQ-167"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* The investigator will evaluate these and other criteria to determine whether a participant should be excluded from this study.",
            "criterions": [
                {
                    "exact_snippets": "The investigator will evaluate these and other criteria to determine whether a participant should be excluded from this study.",
                    "criterion": "investigator assessment of exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "assessment",
                            "expected_value": "investigator determines participant should be excluded"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Females who are pregnant or breastfeeding.",
            "criterions": [
                {
                    "exact_snippets": "Females who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Females who are ... breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inability to take oral medication, or malabsorption syndrome or any other uncontrolled gastrointestinal condition (e.g., nausea, diarrhea, or vomiting) that might impair the bioavailability of MBQ-167.",
            "criterions": [
                {
                    "exact_snippets": "Inability to take oral medication",
                    "criterion": "ability to take oral medication",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "malabsorption syndrome",
                    "criterion": "malabsorption syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any other uncontrolled gastrointestinal condition (e.g., nausea, diarrhea, or vomiting)",
                    "criterion": "uncontrolled gastrointestinal condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that might impair the bioavailability of MBQ-167",
                    "criterion": "impairment of MBQ-167 bioavailability",
                    "requirements": [
                        {
                            "requirement_type": "risk",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active malignancies other than advanced breast cancer will be excluded from the study.",
            "criterions": [
                {
                    "exact_snippets": "Active malignancies other than advanced breast cancer will be excluded",
                    "criterion": "active malignancies (other than advanced breast cancer)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "key"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [
        {
            "line": "* The investigator will evaluate these and other criteria to determine whether a participant can be included in this study.",
            "criterions": []
        }
    ],
    "failed_exclusion": [
        {
            "line": "* Participants who have received any anticancer treatment within 4 weeks or any investigational agent within 28 days prior to the first dose of trial drug or who have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment.",
            "criterions": [
                {
                    "exact_snippets": "received any anticancer treatment within 4 weeks prior to the first dose of trial drug",
                    "criterion": "anticancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "received any investigational agent within 28 days prior to the first dose of trial drug",
                    "criterion": "investigational agent administration",
                    "requirements": [
                        {
                            "requirement_type": "time since last administration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment",
                    "criterion": "acute toxicity from previous anticancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "toxicity grade",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "Grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants who have received any anticancer treatment within 4 weeks or any investigational agent within 28 days prior to the first dose of trial drug or who have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment.",
            "criterions": [
                {
                    "exact_snippets": "received any anticancer treatment within 4 weeks prior to the first dose of trial drug",
                    "criterion": "anticancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "received any investigational agent within 28 days prior to the first dose of trial drug",
                    "criterion": "investigational agent",
                    "requirements": [
                        {
                            "requirement_type": "time since last treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "have not recovered from any acute toxicity greater than Grade 0 or 1 related to previous anticancer treatment",
                    "criterion": "acute toxicity related to previous anticancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "toxicity grade",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "Grade"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}